Microbicide Trials Network

MTN-030/IPM 041

A Phase I trial of a vaginal ring containing the ARV drug dapivirine and the contraceptive hormone levonorgestrel, an important first step toward developing a product for women that could both protect against HIV and prevent unplanned  pregnancy.

 

See

MTN begins first trial of new dapivirine ring with both anti-HIV drug and contraceptive

03-May-2017

 

See Also

MTN-030/IPM 041 Protocol